
Keywords: Prevención secundaria cardiovascular; Policomprimido; Adherencia; Coste-efectividad; Secondary cardiovascular prevention; Polypill; Adherence; Cost-effectiveness; ACEI; angiotensin-converting enzyme inhibitors; NNT; number of patients needed to treat; QA